Molecular mechanisms of myocardial remodeling. The role of aldosterone

Claude Delcayre1, Bernard Swynghedauw

  • 1CD Directeur de Recherches au CNRS, U217-INSERM, Hôpital Lariboisière, Paris, France.

Insights

Aldosterone contributes to cardiac remodeling and fibrosis, particularly after myocardial infarction and in heart failure. Blocking aldosterone, for example with spironolactone, reduces fibrosis and improves outcomes.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Evolutionary Medicine

Background:

  • Cardiac remodeling (CR) is influenced by mechanical stress, aging, and neurohormonal factors.
  • Aldosterone plays a key role in cardiovascular fibrosis, especially with high sodium intake.
  • Aldosterone's effects are mediated through its receptor, influencing gene expression and fibrosis pathways.

Purpose of the Study:

  • To explore the role of aldosterone in cardiac remodeling and fibrosis.
  • To investigate the mechanisms of aldosterone-induced cardiac fibrosis.
  • To examine the impact of aldosterone production in myocardial infarction and heart failure.

Main Methods:

  • Review of evidence on aldosterone's role in cardiovascular system.
  • Analysis of aldosterone receptor pathways and gene expression.
  • Examination of clinical trial data (e.g., RALES) and animal studies on myocardial infarction and heart failure models.

Main Results:

  • Aldosterone induces fibrosis throughout the cardiovascular system, potentiated by high sodium diets.
  • Aldosterone upregulates angiotensin II type I and glucocorticoid receptors.
  • Spironolactone demonstrated significant benefits in heart failure, linked to reduced fibrosis.
  • Intracardiac aldosterone production occurs, regulated by diet and angiotensin II, and is elevated post-myocardial infarction and in heart failure.

Conclusions:

  • Local aldosterone and angiotensin II production are critical in regulating fibrosis after myocardial infarction.
  • Activated aldosterone production, both adrenal and cardiac, contributes detrimentally to fibrosis during heart failure as part of the neurohormonal response.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...